SCHEMBL10334178

SCHEMBL10334178

O=C(O)c1ccc(/N=N/c2ccc(C(=O)O)c(O)c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.59
MEN1 O00255 5/20 0.59
PDE4A P27815 1/20 0.59
BLVRB P30043 1/20 0.59
KDR P35968 1/20 0.59
HTT P42858 1/20 0.59
TRPA1 O75762 1/20 0.58
CYP2C19 P33261 2/20 0.57
HSD17B10 Q99714 2/20 0.57
CYP1A2 P05177 1/20 0.57
HPGD P15428 1/20 0.57
MAPK1 P28482 1/20 0.57
TDP1 Q9NUW8 5/20 0.57
THRB P10828 3/20 0.57
RECQL P46063 2/20 0.57
APP P05067 1/20 0.57
BLM P54132 1/20 0.57
CD69 Q07108 1/20 0.56
ALDH1A1 P00352 6/20 0.50
POLB P06746 4/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10334179 1.00 KMT2A (0.59) KMT2AMEN1PDE4ABLVRBKDR
SCHEMBL3385330 0.91 MEN1 (0.70) KMT2AMEN1PDE4ABLVRBKDR
SCHEMBL26730466 0.91 MEN1 (0.70) KMT2AMEN1PDE4ABLVRBKDR
SCHEMBL1624756 0.91 MEN1 (0.70) KMT2AMEN1PDE4ABLVRBKDR
SCHEMBL10930328 0.89 MEN1 (0.68) KMT2AMEN1PDE4ABLVRBKDR
SCHEMBL16899826 0.86 MEN1 (0.82) KMT2AMEN1PDE4ABLVRBKDR
SCHEMBL16899827 0.86 MEN1 (0.82) KMT2AMEN1PDE4ABLVRBKDR
SCHEMBL6934004 0.85 TRPA1 (0.62) KMT2AMEN1PDE4ABLVRBKDR
SCHEMBL1624852 0.84 MEN1 (0.85) KMT2AMEN1PDE4ABLVRBKDR
SCHEMBL3386039 0.84 MEN1 (0.85) KMT2AMEN1PDE4ABLVRBKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4933330-A PSORIASIS DAK-LABORATORIET (DK) 1990-06-12 US disclosed
EP-0291159-A2 Aminosalicylic-acid derivatives for the treatment of psoriasis DAK-LABORATORIET A/S (DK) 1988-11-17 EP disclosed